Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

XERIS PHARMACEUTICALS INC (XERS)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-21Mar-31-21Dec-31-20Sep-30-20Jun-30-20Jun-05-20Mar-31-20Mar-05-20
   10-Q8-K10-K10-Q10-Q8-K10-Q8-K
Net income  -27.5-18.4-21.9-16.0-24.2-24.1-29.2-29.2
Depreciation and amortization  0.7 0.40.40.3 0.3 
Stock-based compensation  5.0 2.12.12.1 2.0 
Change in working capital   [+]-5.7 30.2-8.4-3.2 -3.1 
Other operating activities  -16.4 -21.85.01.3 1.0 
Cash from operations  -44.0 -10.9-17.0-23.8 -28.9 
   
Capital expenditures  -0.6 -0.20.0-0.1 0.0 
Purchases of short-term investments    -101.8     
Other cash from investing  43.5 109.2-60.717.5 8.7 
Cash from investing  42.9 7.2-60.717.3 8.7 
   
Issuance of common stock, net  27.0  3.020.1 42.7 
Option exercises  0.5 0.30.10.4   
Financing costs    -0.1-1.0-4.6   
Other cash from financing  0.7 3.69.145.4 -2.7 
Cash from financing  27.1 3.313.169.6 40.1 
   
Free cash flow  -44.6 -11.1-17.0-23.9 -29.0 
        Per share (diluted)  ($0.67) ($0.26)($0.37)($0.63) ($0.88) 
   
Cash paid for interest  3.2 0.90.91.5 1.3 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy